Abstract The ATP synthase complex is a critical enzyme in the energetic pathways of cells because it is the enzyme complex that produces the majority of cellular ATP. It has been shown to be involved in several cardiac phenotypes including heart failure and preconditioning, a cellular protective mechanism. Understanding the regulation of this enzyme is important in understanding the mechanisms behind these important phenomena. Recently there have been several posttranslational modifications (PTM) reported for various subunits of this enzyme complex, opening up the possibility of differential regulation by these PTMs. Here we discuss the known PTMs in the heart and other mammalian tissues and their implication to function and regulation of the ATP synthase.
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Keywords ATP synthase . Post-translational modification . Heart Heart failure is a major health concern and has a complex and diverse etiology, the mechanisms of which are still under intense study. The energetics of the heart, and thus the mitochondria, are integrally involved in the causes and phenotype of heart failure (Marin-Garcia and Goldenthal 2008, Murray et al. 2007 ). Mitochondria and modulation of their energetic pathways have also been implicated in preconditioning (PC), a phenomenon by which certain triggers activate a cardioprotective state that minimizes heart damage during ischemic events (for reviews see: (Foster et al. 2008 , Halestrap et al. 2007 , Murphy and Steenbergen 2008 . There have been several reports of the modulation of the mitochondrial ATP synthase complex in various cardiac phenomena (for reviews see: (Das 2003 , Grover et al. 2008 . Specifically, it has been observed that there is an increase in ATP hydrolysis by the ATP synthase complex in ischemic myocardium (Grover et al. 2004) which is hypothesized to contribute to the overall depletion of the cellular ATP pool during ischemia. Two cardioprotective drugs, diazoxide and adenosine, have been shown to cause the downmodulation of activity (Comelli et al. 2007 ) and posttranslational modification (PTM) (Arrell et al. 2006 ) of this enzyme complex, respectively. The PTM was found to be phosphorylation of the β subunit of the complex at up to five amino acid residues. Given this enzyme's involvement in these cardiac phenomena, it is critically important to understand the ways in which the ATP synthase complex can be regulated in the heart.
The mitochondrial ATP synthase complex, the primary site of ATP synthesis in myocytes, is a large multisubunit protein complex comprised of a membrane (F o ) domain and soluble (F 1 ) domain. The F o domain contains both the membrane spanning a and c subunits that are responsible for proton translocation, as well as several other subunits that are a part of the peripheral stalk of the enzyme and are involved in regulation of structure and function. The F 1 domain contains the α, β, δ, γ, and ε subunits that are involved in both catalysis and regulation. Much is known about the structure and function of this enzyme and its subunits (Ackerman and Tzagoloff 2005 , Feniouk and Yoshida 2008 , Pedersen 2007 , but until recently there was essentially no knowledge regarding the PTM-dependent modulation/regulation of the protein subunits in the context of mammalian systems.
The recent developments of PTM-specific mass spectrometry-based methods (MS), as well as selective dyes and antibodies, have allowed for the detection of a surprising number of PTMs in subunits of ATP synthase. Examples include phosphorylation, acetylation, trimethylation, nitration, s-nitrosylation and tryptophan oxidation (Tables 1 and 2 ). While some of these PTMs have been associated with specific biological processes or diseases, the biggest ongoing challenge is to find direct functional implications for these PTMs. Studies are needed to examine the link between each PTM and the resulting function. This review will discuss the ATP synthase subunit PTMs found in the heart (Table 1) and briefly compare these with PTMs found in other mammalian tissues (Table 2) .
Phosphorylation
Phosphorylation is one of the most commonly and extensively studied PTMs in mammalian systems (Sefton and Shenolikar 2001). Several mitochondrial proteins (e.g. pyruvate dehydrogenase) have been known to be the targets of phosphorylation-specific regulation for over a decade. Until recently, it was suspected that the global mitochondrial proteome was not highly phosphorylated, but with the recent advent of new technologies for studying the phosphorylation of proteins, a new picture has emerged of an extensively phosphorylated and dynamically regulated mitochondrial proteome (Agnetti et al. 2007 , Foster et al. 2008 , Pagliarini and Dixon 2006 and see Foster et al. in this journal) . Several studies have made use of these new technologies to study the phosphorylation of the ATP synthase complex.
One such new reagent is the commercially available phosphorylation targeted dye ProQ Diamond (Invitrogen). This dye has been used both to observe the phosphorylated proteins present in the mitochondria (Murray et al. 2004 , Schulenberg et al. 2004 ) and in the ATP synthase complex specifically (Murray et al. 2004) . Hopper et al. used this dye in conjunction with 2D gels and MS identification of proteins to visualize the phospho-proteome of the mitochondrial matrix (Hopper et al. 2006) . Through this study, they observed that the α, β, γ, c, and O subunits of the ATP synthase complex had ProQ Diamond positive signal in 2D gels of mitochondria from pig hearts. The α and β subunits were also observed to react with the ProQ Diamond dye in ATP synthase complex immuno-precipitated from bovine heart mitochondria (Murray et al. 2004) . While this dye is designed to bind to the negative charge of the phosphate group, it can also bind to other negatively charged moieties, such as sequential negatively charged amino acid residues. Therefore, datasets generated using this dye can include false positives which must be eliminated using other analyses. To improve the specificity of their study, Hopper 
